Related references
Note: Only part of the references are listed.LC-MS/MS screening method for designer amphetamines, tryptamines, and piperazines in serum
Ariane Wohlfarth et al.
ANALYTICAL AND BIOANALYTICAL CHEMISTRY (2010)
Beta-keto amphetamines: studies on the metabolism of the designer drug mephedrone and toxicological detection of mephedrone, butylone, and methylone in urine using gas chromatography-mass spectrometry
Markus R. Meyer et al.
ANALYTICAL AND BIOANALYTICAL CHEMISTRY (2010)
Metabolism of Designer Drugs of Abuse: An Updated Review
Markus R. Meyer et al.
CURRENT DRUG METABOLISM (2010)
Determination of a new designer drug, N-hydroxy-3,4-methylenedioxymethamphetamine and its metabolites in rats using ultra-performance liquid chromatography-tandem mass spectrometry
Ruri Kikura-Hanajiri et al.
FORENSIC SCIENCE INTERNATIONAL (2010)
Differentiation of regioisomeric ring-substituted fluorophenethylamines with product ion spectrometry
F. Westphal et al.
FORENSIC SCIENCE INTERNATIONAL (2010)
Studies on 1-(2-phenethyl)-4-(N-propionylanilino)piperidine (fentanyl) and related compounds VII. Quantification of α-methylfentanyl metabolites excreted in rat urine
Shinichi Sato et al.
FORENSIC SCIENCE INTERNATIONAL (2010)
Chemical analysis of four capsules containing the controlled substance analogues 4-methylmethcathinone, 2-fluoromethamphetamine, α-phthalimidopropiophenone and N-ethylcathinone
Andrew Camilleri et al.
FORENSIC SCIENCE INTERNATIONAL (2010)
Chemical analysis of synthetic cannabinoids as designer drugs in herbal products
Nahoko Uchiyama et al.
FORENSIC SCIENCE INTERNATIONAL (2010)
Increase in split ratio enables detection of underivatized N-hydroxy-3,4-methylenedioxymethamphetamine and N-hydroxy-3,4-methylenedioxyamphetamine by capillary GC-MS
Kenji Tsujikawa et al.
FORENSIC TOXICOLOGY (2010)
Simultaneous analysis of six novel hallucinogenic (tetrahydrobenzodifuranyl)aminoalkanes (FLYs) and (benzodifuranyl)aminoalkanes (DragonFLYs) by GC-MS, LC-MS, and LC-MS-MS
Kei Zaitsu et al.
FORENSIC TOXICOLOGY (2010)
Metabolism and toxicological analyses of hallucinogenic tryptamine analogues being abused in Japan
Tooru Kamata et al.
FORENSIC TOXICOLOGY (2010)
Preventive doping control screening analysis of prohibited substances in human urine using rapid-resolution liquid chromatography/high-resolution time-of-flight mass spectrometry
A. Vonaparti et al.
RAPID COMMUNICATIONS IN MASS SPECTROMETRY (2010)
Mass spectrometric approaches in impaired driving toxicology
Hans H. Maurer
ANALYTICAL AND BIOANALYTICAL CHEMISTRY (2009)
Determination of ketamine and amphetamines in hair by LC/MS/MS
Maria Jesus Tabernero et al.
ANALYTICAL AND BIOANALYTICAL CHEMISTRY (2009)
Structure elucidation of a new designer benzylpiperazine: 4-Bromo-2,5-dimethoxybenzylpiperazine
Folker Westphal et al.
FORENSIC SCIENCE INTERNATIONAL (2009)
A fatal poisoning involving Bromo-Dragonfly
Mette Findal Andreasen et al.
FORENSIC SCIENCE INTERNATIONAL (2009)
Fluoromethcathinone, a new substance of abuse
R. P. Archer
FORENSIC SCIENCE INTERNATIONAL (2009)
Mass and NMR spectroscopic characterization of 3,4-methylenedioxypyrovalerone: A designer drug with α-pyrrolidinophenone structure
Folker Westphal et al.
FORENSIC SCIENCE INTERNATIONAL (2009)
Determination of the metabolites of the new designer drugs bk-MBDB and bk-MDEA in human urine
Kei Zaitsu et al.
FORENSIC SCIENCE INTERNATIONAL (2009)
A rapid method for the extraction, enantiomeric separation and quantification of amphetamines in hair
Sabina Strano-Rossi et al.
FORENSIC SCIENCE INTERNATIONAL (2009)
Identification of a cannabimimetic indole as a designer drug in a herbal product
Nahoko Uchiyama et al.
FORENSIC TOXICOLOGY (2009)
High throughput chiral analysis of urinary amphetamines by GC-MS using a short narrow-bore capillary column
Hiroshi Fujii et al.
FORENSIC TOXICOLOGY (2009)
Construction of calibration-locking databases for rapid and reliable drug screening by gas chromatography-mass spectrometry
Keiko Kudo et al.
FORENSIC TOXICOLOGY (2009)
New designer drug α-pyrrolidinovalerophenone (PVP): studies on its metabolism and toxicological detection in rat urine using gas chromatographic/mass spectrometric techniques
Christoph Sauer et al.
JOURNAL OF MASS SPECTROMETRY (2009)
Multi-residue analysis of eight thioamphetamine designer drugs in human urine by liquid chromatography/tandem mass spectrometry
Maria Nieddu et al.
RAPID COMMUNICATIONS IN MASS SPECTROMETRY (2009)
Creation and application of psychoactive designer drugs data library using liquid chromatography with photodiode array spectrophotometry detector and gas chromatography-mass spectrometry
Misako Takahashi et al.
TALANTA (2009)
Studies on distribution and metabolism of para-methoxymethamphetamine (PMMA) in rats after subcutaneous administration
Miroslava Rohanova et al.
TOXICOLOGY (2009)
Metabolism and toxicological detection of the designer drug 4-chloro-2,5-dimethoxyamphetamine in rat urine using gas chromatography-mass spectrometry
Andreas H. Ewald et al.
ANALYTICAL AND BIOANALYTICAL CHEMISTRY (2008)
Metabolism and toxicological detection of the designer drug N-(1-phenylcyclohexyl)-3-methoxypropanamine (PCMPA) in rat urine using gas chromatography-mass spectrometry
Christoph Sauer et al.
FORENSIC SCIENCE INTERNATIONAL (2008)
Determination of a newly encountered designer drug p-methoxyethylamphetamine and its metabolites in human urine and blood
Kei Zaitsu et al.
FORENSIC SCIENCE INTERNATIONAL (2008)
Conjugates of p-hydroxymethamphetamine and 4-hydroxy-3-methoxymethamphetamine in blood obtained from methamphetamine and 3,4-methylenedioxymethamphetamine users: analysis by LC-MS-MS
Noriaki Shima et al.
FORENSIC TOXICOLOGY (2008)
Simultaneous analysis of six phenethylamine-type designer drugs by TLC, LC-MS, and GC-MS
Kohei Kanai et al.
FORENSIC TOXICOLOGY (2008)
Discrimination and identification of regioisomeric β-keto analogues of 3,4-methylenedioxyamphetamines by gas chromatography-mass spectrometry
Kei Zaitsu et al.
FORENSIC TOXICOLOGY (2008)
An epidemic of fatal 3-methylfentanyl poisoning in Estonia
Ilkka Ojanpera et al.
INTERNATIONAL JOURNAL OF LEGAL MEDICINE (2008)
Detection of 1-benzylpiperazine and 1-(3-trifluoromethylphenyl)-piperazine in urine analysis specimens using GC-MS and LC-ESI-MS
Shawn P. Vorce et al.
JOURNAL OF ANALYTICAL TOXICOLOGY (2008)
Metabolism and toxicological detection of a new designer drug, N-(1-phenylcyclohexyl)propanamine, in rat urine using gas chromatography-mass spectrometry
Christoph Sauer et al.
JOURNAL OF CHROMATOGRAPHY A (2008)
Designer drug 2,5-dimethoxy-4-methyl-amphetamine (DOM, STP): Involvement of the cytochrome P450 isoenzymes in formation of its main metabolite and detection of the latter in rat urine as proof of a drug intake using gas chromatography-mass spectrometry
Andreas H. Ewald et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2008)
LC-MS analysis of trimethoxyamphetamine designer drugs (TMA series)from urine samples
Maria Nieddu et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2008)
Analysis of phenethylamines and tryptamines in designer drugs using gas chromatography-mass spectrometry
Misako Takahashi et al.
JOURNAL OF HEALTH SCIENCE (2008)
Discrimination and identification of the six aromatic positional isomers of trimethoxyamphetamine (TMA) by gas chromatography-mass spectrometry (GC-MS)
Kei Zaitsu et al.
JOURNAL OF MASS SPECTROMETRY (2008)
New designer drugs N-(1-phenylcyclohexyl)-2-ethoxyethanamine (PCEEA) and N-(1-phenylcyclohexyl)-2-methoxyethanamine (PCMEA):: Studies on their metabolism and toxicological detection in rat urine using gas chromatographic/mass spectrometric techniques
Christoph Sauer et al.
JOURNAL OF MASS SPECTROMETRY (2008)
Liquid chromatography-atmospheric pressure ionization electrospray mass spectrometry determination of hallucinogenic designer drugs in urine of consumers
Simona Pichini et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2008)
Neuropsychotoxicity of abused drugs: Molecular and neural mechanisms of neuropsychotoxicity induced by methamphetamine, 3,4-methylenedioxymethamphetamine (Ecstasy), and 5-methoxy-N,N-diisopropyltryptamine (Foxy)
Takayuki Nakagawa et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2008)
Analytical data of designated substances (Shitei-Yakubutsu) controlled by the pharmaceutical affairs law in Japan, part II: Color test and TLC
Nahoko Uchiyama et al.
YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN (2008)
Chemical identification of 2,5-dimethoxy-4-bromoamphetamine (DOB)
Jose Luiz da Costa et al.
FORENSIC SCIENCE INTERNATIONAL (2007)
Direct determination of glucuronide and sulfate of 4-hydroxy-3-methoxymethamphetamine, the main metabolite of MDMA, in human urine
Noriaki Shima et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2007)
Metabolism and toxicological detection of the designer drug 4-iodo-2,5-dimethoxy-amphetamine (DOI) in rat urine using gas chromatography-mass spectrometry
Andreas H. Ewald et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2007)
The disposition into hair of new designer drugs; methylone, MBDB and methcathinone
Ruri Kikura-Hanajiri et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2007)
Simultaneous determination of 13 amphetamine related drugs in human whole blood using an enhanced polymer column and gas chromatography-mass spectrometry
Keiko Kudo et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2007)
Mass spectral and NMR spectral data of two new designer drugs with an α-aminophenone structure:: 4'-Methyl-α-pyrrolidinohexanophenone and 4'-methyl-α-pyrrolidinobutyrophenone
Folker Westphal et al.
FORENSIC SCIENCE INTERNATIONAL (2007)
5-Methoxy-N,N-diisopropyltryptamine (Foxy), a selective and high affinity inhibitor of serotonin transporter
C. Sogawa et al.
TOXICOLOGY LETTERS (2007)
Acute confusional state after designer tryptamine abuse
Masanari Itokawa et al.
PSYCHIATRY AND CLINICAL NEUROSCIENCES (2007)
The effects of non-medically used psychoactive drugs on monoamine neurotransmission in rat brain
Fumiko Nagai et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2007)
Phytosterols and anabolic agents versus designer drugs
H. F. De Brabander et al.
ANALYTICA CHIMICA ACTA (2007)
Studies on the toxicological detection of the designer drug 4-bromo-2,5-dimethoxy-β-phenethylamine (2C-B) in rat urine using gas chromatography-mass spectrometry
Denis S. Theobald et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2007)
Preventive doping control analysis: liquid and gas chromatography time-of-flight mass spectrometry for detection of designer steroids
Costas G. Georgakopoulos et al.
RAPID COMMUNICATIONS IN MASS SPECTROMETRY (2007)
Mass spectrometry in sports drug testing: Structure characterization and analytical assays
Mario Thevis et al.
MASS SPECTROMETRY REVIEWS (2007)
Studies on the metabolism and toxicological detection of the designer drug 2,5-dimethoxy-4-methyl-β-phenethylamine (2C-D) in rat urine using gas chromatographic/mass spectrometric techniques
Denis S. Theobald et al.
JOURNAL OF MASS SPECTROMETRY (2006)
Studies on the metabolism and toxicological detection of the designer drug 4-ethyl-2,5-dimethoxy-β-phenethylamine (2C-E) in rat urine using gas chromatographic-mass spectrometric techniques
Denis S. Theobald et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2006)
Rapid screening for and simultaneous semiquantitative analysis of thirty abused drugs in human urine samples using gas chromatography-mass spectrometry
Tomomi Ishida et al.
JOURNAL OF ANALYTICAL TOXICOLOGY (2006)
Use of liquid chromatography-mass spectrometry and a hydrolytic technique for the detection and structure elucidation of a novel synthetic vardenafil designer drug added illegally to a natural herbal dietary supplement
John C. Reepmeyer et al.
JOURNAL OF CHROMATOGRAPHY A (2006)
New designer drug 4-iodo-2,5-dimethoxy-β-phenethylamine (2C-I):: Studies on its metabolism and toxicological detection in rat urine using gas chromatographic/mass spectrometric and capillary electrophoretic/mass spectrometric techniques
Denis S. Theobald et al.
JOURNAL OF MASS SPECTROMETRY (2006)
Determination of drugs of abuse and their metabolites in human plasma by liquid chromatography-mass spectrometry -: An application to 156 road fatalities
M Concheiro et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2006)
Metabolism of the psychotomimetic tryptamine derivative 5-methoxyn, N,N-diisopropyltryptamine in humans:: Identification and quantification of its urinary metabolites
T Kamata et al.
DRUG METABOLISM AND DISPOSITION (2006)
Urine testing for designer steroids by liquid chromatography with androgen bioassay detection and electrospray quadrupole time-of-flight mass spectrometry identification
MWF Nielen et al.
ANALYTICAL CHEMISTRY (2006)
Hallucinogen-like actions of 5-methoxy-N,N-diisopropyltryptamine in mice and rats
WE Fantegrossi et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2006)
Rapid simultaneous determination of amphetamine, methamphetamine, 3,4-methylenedioxyamphetamine, 3,4-methylenedioxymethamphetamine, and 3,4-methylenedioxyethylamphetamine in urine by fast gas chromatography-mass spectrometry
KL Klette et al.
JOURNAL OF ANALYTICAL TOXICOLOGY (2005)
Studies on the metabolism and toxicological detection of the designer drug 4-methylthioamphetamine (4-MTA) in human urine using gas chromatography-mass spectrometry
AH Ewald et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2005)
Studies on the metabolism and toxicological detection of the new designer drug 4′-methyl-α-pyrrolidinobutyrophenone (MPBP) in rat urine using gas chromatography-mass spectrometry
FT Peters et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2005)
The prevalence of MDMA/MDA in both hair and urine in drug users
E Han et al.
FORENSIC SCIENCE INTERNATIONAL (2005)
Screening for unknown synthetic steroids in human urine by liquid chromatography-tandem mass spectrometry
M Thevis et al.
JOURNAL OF MASS SPECTROMETRY (2005)
Metabolism of designer drugs of abuse
RF Staack et al.
CURRENT DRUG METABOLISM (2005)
Development of simultaneous gas chromatography-mass spectrometric and liquid chromatography-electrospray ionization mass spectrometric determination method for the new designer drugs, N-benzylpiperazine (BZP), 1-(3-trifluoromethylphenyl)piperazine (TFMPP) and their main metabolites in urine
H Tsutsumi et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2005)
Isomeric Fluoro-methoxy-phenylalkylamines:: a new series of controlled-substance analogues (designer drugs)
P Rösner et al.
FORENSIC SCIENCE INTERNATIONAL (2005)
Another designer steroid: discovery, synthesis, and detection of 'madol' in urine
MH Sekera et al.
RAPID COMMUNICATIONS IN MASS SPECTROMETRY (2005)
Chemistry, pharmacology, toxicology, and hepatic metabolism of designer drugs of the amphetamine (ecstasy), piperazine, and pyrrolidinophenone types - A synopsis
HH Maurer et al.
THERAPEUTIC DRUG MONITORING (2004)
A general screening and confirmation approach to the analysis of designer tryptamines and phenethylamines in blood and urine using GC-EI-MS and HPLC-electrospray-MS
SP Vorce et al.
JOURNAL OF ANALYTICAL TOXICOLOGY (2004)
Toxicological detection of the new designer drug 1-(4-methoxyphenyl)piperazine and its metabolites in urine and differentiation from an intake of structurally related medicaments using gas chromatography-mass spectrometry
RF Staack et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2003)
Optimized glucuronide hydrolysis for the detection of psilocin in human urine samples
T Kamata et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2003)
Metabolism of the new designer drug α-pyrrolidinopropiophenone (PPP) and the toxicological detection of PPP and 4′-methyl-α-pyffolidinopropiophenone (MPPP) studied in rat urine using gas chromatography-mass spectrometry
D Springer et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2003)
Metabolism and toxicological detection of the new designer drug 4′-methoxy-α-pyrrolidinopropiophenone studied in rat urine using gas chromatography-mass spectrometry
D Springer et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2003)
Metabolism and toxicological detection of the new designer drug 3′,4′-methylenedioxy-α-pyrrolidinopropiophenone studied in urine using gas chromatography-mass spectrometry
D Springer et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2003)
Foxy, a designer tryptamine hallucinogen
R Meatherall et al.
JOURNAL OF ANALYTICAL TOXICOLOGY (2003)
New designer drug 4′-methyl-α-pyrrolidinohexanophenone:: studies on its metabolism and toxicological detection in urine using gas chromatography-mass spectrometry
D Springer et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2003)
New designer drug p-methoxymethamphetamine:: studies on its metabolism and toxicological detection in urine using gas chromatography-mass spectrometry
RF Staack et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2003)
Screening for and validated quantification of amphetamines and of amphetamine- and piperazine-derived designer drugs in human blood plasma by gas chromatography/mass spectrometry
FT Peters et al.
JOURNAL OF MASS SPECTROMETRY (2003)
Piperazine-derived designer drug 1-(3-chlorophenyl)piperazine (mCPP): GC-MS studies on its metabolism and its toxicological detection in rat urine including analytical differentiation from its precursor drugs trazodone and nefazodone
RF Staack et al.
JOURNAL OF ANALYTICAL TOXICOLOGY (2003)
Therapeutic and adverse actions of serotonin transporter substrates
RB Rothman et al.
PHARMACOLOGY & THERAPEUTICS (2002)
Studies on the metabolism and toxicological detection of the new designer drug 4′-methyl-α-pyrrolidinopropiophenone in urine using gas chromatography-mass spectrometry
D Springer et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2002)
Studies on the metabolism and toxicological detection of the new designer drug N-benzylpiperazine in urine using gas chromatography-mass spectrometry
RF Staack et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2002)
Automated headspace solid-phase dynamic extraction for the determination of amphetamines and synthetic designer drugs in hair samples
F Musshoff et al.
JOURNAL OF CHROMATOGRAPHY A (2002)
Toxicokinetics of amphetamines: Metabolism and toxicokinetic data of designer drugs, amphetamine, methamphetamine, and their N-alkyl derivatives
T Kraemer et al.
THERAPEUTIC DRUG MONITORING (2002)
Piperazine-like compounds:: a new group of designer drugs-of-abuse on the European market
D de Boer et al.
FORENSIC SCIENCE INTERNATIONAL (2001)
Toxicokinetics and analytical toxicology of amphetamine-derived designer drugs ('Ecstasy')
HH Maurer et al.
TOXICOLOGY LETTERS (2000)
Analysis of underivatized amphetamines and related phenethylamines with high-performance liquid chromatography -: Atmospheric pressure chemical ionization mass spectrometry
MJ Bogusz et al.
JOURNAL OF ANALYTICAL TOXICOLOGY (2000)
Semi-automated 96-well liquid-liquid extraction for quantitation of drugs in biological fluids
NY Zhang et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2000)
Share Paper
